Small Molecule MIF Modulation Enhances Ferroptosis by Impairing DNA Repair Mechanisms

Ferroptosis is a form of regulated cell death that can be modulated by small molecules and has the potential for the development of therapeutics for oncology. Although excessive lipid peroxidation is the defining hallmark of ferroptosis, DNA damage may also play a significant role. In this study, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced Science 2024-08, Vol.11 (32), p.e2403963-n/a
Hauptverfasser: Chen, Deng, Zhao, Chunlong, Zhang, Jianqiu, Knol, Catharina W. J., Osipyan, Angelina, Majerníková, Nad'a, Chen, Tingting, Xiao, Zhangping, Adriana, Jeaunice, Griffith, Andrew J., Gamez, Abel Soto, Wouden, Petra E., Coppes, Robert P., Dolga, Amalia M., Haisma, Hidde J., Dekker, Frank J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ferroptosis is a form of regulated cell death that can be modulated by small molecules and has the potential for the development of therapeutics for oncology. Although excessive lipid peroxidation is the defining hallmark of ferroptosis, DNA damage may also play a significant role. In this study, a potential mechanistic role for MIF in homologous recombination (HR) DNA repair is identified. The inhibition or genetic depletion of MIF or other HR proteins, such as breast cancer type 1 susceptibility protein (BRCA1), is demonstrated to significantly enhance the sensitivity of cells to ferroptosis. The interference with HR results in the translocation of the tumor suppressor protein p53 to the mitochondria, which in turn stimulates the production of reactive oxygen species. Taken together, the findings demonstrate that MIF‐directed small molecules enhance ferroptosis via a putative MIF‐BRCA1‐RAD51 axis in HR, which causes resistance to ferroptosis. This suggests a potential novel druggable route to enhance ferroptosis by targeted anticancer therapeutics in the future. The development of therapeutics to modulate ferroptosis has potential for oncology. Although excessive lipid peroxidation is the defining hallmark of ferroptosis, DNA damage may also play a role. Here, the data demonstrate that MIF‐ and homologous recombination (HR)‐directed small molecules enhance ferroptosis via a putative MIF‐BRCA1‐RAD51 axis in HR, which suggests a potential novel druggable route to enhance ferroptosis.
ISSN:2198-3844
2198-3844
DOI:10.1002/advs.202403963